EsoBiotec
ActiveSummary
EsoBiotec has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12.4m and a net result of €7.7m, of which €42.6m non-recurring income. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 69% of 239 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Board 4
Day-to-day management 1
Permanent representatives 1
Statutory auditor 2
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Jean-Pierre LATERE |
|
| Angela Thompson |
|
| Carsten Linnemann |
|
| Philippe Parone |
|
| KNCL SRL |
|
| Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises |
|
| KPMG Réviseurs d'Entreprises |
|
| Jean-Pierre LATERE DWAN'ISA |
|
| Erica Whittaker |
|
| FONDS DE CAPITAL A RISQUE 2020 |
|
| Laura RODRIGUEZ GALLEGO |
|
| Michel Briejer |
|
| Paul Rennert |
|
| Emmanuel Lacroix |
|
| Héléna Pozios |
|
Owners and capital
Owners
1 ownerChain of control
- Neogene TherapeuticsNL
- EsoBiotec
Highest known parent: Neogene Therapeutics (Netherlands). The sources do not say who stands above it.
Owners 1
- Neogene TherapeuticsNLparentSourceown accounts 2025100%
Stated earlier (1)
An older source named these owners; newer accounts no longer list them.
- 13.16%
According to the 2025 annual accounts of EsoBiotec and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- Thuja Capital Healthcare Fund III Coöperatief U.A. 595 shares
- FONDS DE CAPITAL A RISQUE 2020 (BE 0667.964.566) 298 shares
- Société Régionale d'Investissement de Wallonie (BE 0219.919.487) 297 shares
- KNCL (BE 0645.689.309) 100 shares · €90,000
- Mireille KABAMBA MWIKA 55 shares · €50,000
- Origène NYANGUILE 28 shares · €25,000
- Philippe PARONE 33 shares · €30,000
- Natacha VAN HOEKEN 33 shares · €30,000
- Zoor LUONO 28 shares · €25,000
- LATERE DWAN'ISA Jean-Pierre 1,250 shares (50%) · €1,250
- KABAMBA NKONGOLO 1,250 shares (50%) · €1,250
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 28-05-2025 Capital stated in the deed · €15,432,208.13 · 1,482,129 shares
- 23-05-2025 Capital increase of €1,179,246.60 · to €15,432,208.13 · 93,591 new shares · in cash
- 26-02-2025 Capital increase of €1,999,961.19 · to €14,252,961.53 · 158,683 new shares · in cash
- 29-08-2024 Capital increase of €2,000,000 · to €8,253,040.15 · 158,686 new shares · “apport de créance certaine,liquide et exigible”
- 29-08-2024 Capital increase of €3,999,960.19 · to €12,253,000.34 · 317,369 new shares · in cash
- 16-06-2022 Capital increase of €3,750,810.23 · to €6,253,040.15 · 297,600 new shares · in cash
- 18-05-2022 Capital stated in the deed · €2,502,229.92 · 456,200 shares
- 24-12-2021 Capital increase of €749,909.97 · to €2,502,229.92 · 595 new shares
Show 3 older capital entries
- 13-10-2021 Capital increase of €1,499,819.95 · 1,190 new shares
- 16-12-2020 Capital increase of €250,000 · to €252,500 · 277 new shares
- 26-10-2020 Incorporation · €2,500 · 2,500 shares